A behavioural scientist of international standing whose career at Cancer Council Victoria spanned 44 years.
His research over 5 decades has led to a bold new cancer therapy. He discovered, isolated and then produced agents called Colony Stimulating Factors (CSFs), which are naturally occurring regulators of bone marrow growth.
The Nigel Gray Distinguished Fellow in Cancer Prevention. Joined us as a Behavioural Scientist in 1986, and was inaugural Director of the VicHealth Cente for Tobacco Control, before taking on current position.
Director of the Centre for Behavioural Research in Cancer and an NHMRC Principal Research Fellow, with extensive experience evaluating tobacco control policies and programs
Joined as Director of our Victorian Cancer Registry in 1983. In 1986, he was appointed Director of the Cancer Epidemiology Centre, and in 2001 became Deputy Director of the Cancer Control Research Institute.
Dr Michelle Scollo is the senior policy adviser on tobacco at Cancer Council Victoria. Michelle’s research has focussed on the economics of tobacco control.
Professor Gail Risbridger has twice been awarded grants by the Cancer Council. She has investigated the role of oestrogens in prostate malignancy and the early origins of prostate cancer.
Wednesday 5 December 2012
"I had a life-changing experience with an event of cancer in the family. At the time I didn't really know what cancer was and I was determined to apply my scientific skills to learn more about the disease," she said.
Remembered for his pioneering clinical research in paediatric haematology.
The inaugural Colebatch Clinical Research Fellowship was awarded in late 2005 to Associate Professor Kelly-Anne Phillips of the Peter MacCallum Cancer Centre for her work on reducing the burden of breast cancer.
Consultant Medical Oncologist, Head of the Translational Research Group and Head of the Molecular Oncology Laboratory at the Peter MacCallum Cancer Centre. A former recipient of Cancer Council Victoria's Dunlop Fellowship.
The influence of Dr E V (Bill) Keogh has spread widely, yet his name isn't well known to the general public. A modest and private person, his contribution to the development of pathology and public medicine in Australia was incalculable.
Dr Sherene Loi was awarded the Colebatch Clinical Research Fellowship in 2014. Dr Loi, a medical oncologist and scientist at the Peter MacCallum Cancer Centre, will use the five-year fellowship to explore how new targeted therapies can be tailored to an individual’s breast cancer.
Associate Professor Scott, the Dunlop fellow, is working on developing new mouse models to explore the genetic factors driving the behaviour of various types of ovarian cancer and to explore innovative treatment strategies.